Alector (ALEC) EPS (Weighted Average and Diluted) (2020 - 2026)
Alector (ALEC) reported EPS (Weighted Average and Diluted) of -$0.21 for Q1 2026, up 48.78% year-over-year from -$0.14 in Q1 2025, and up 38.24% quarter-over-quarter from -$0.34 in Q4 2025.
Alector (ALEC) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Alector (ALEC) has 7 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.21 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.21, up 48.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.19 (up 4.8% YoY), and the FY2025 annual result was -$1.39, down 13.01% from the prior year.
- EPS (Weighted Average and Diluted) climbed to -$0.21 in Q1 2026 per ALEC's latest filing, from -$0.34 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.12 in Q2 2022 and troughed at -$0.64 in Q4 2022.
- A 5-year average of -$0.35 and a median of -$0.4 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) surged 117.39% in 2022, then plunged 3300.0% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.64 in 2022, then gained by 23.44% to -$0.49 in 2023, then soared by 97.96% to -$0.01 in 2024, then sank by 3300.0% to -$0.34 in 2025, then jumped by 38.24% to -$0.21 in 2026.
- Business Quant data shows ALEC's EPS (Weighted Average and Diluted) at -$0.21 in Q1 2026, -$0.34 in Q4 2025, and -$0.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.21 |
| Dec 31, 2025 | -0.34 |
| Sep 30, 2025 | -0.34 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.41 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.38 |
| Dec 31, 2023 | -0.49 |
| Sep 30, 2023 | -0.53 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | -0.55 |
| Dec 31, 2022 | -0.64 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | 0.12 |
| Mar 31, 2022 | -0.54 |
| Dec 31, 2021 | -0.68 |
| Sep 30, 2021 | 1.49 |
| Jun 30, 2021 | -0.69 |